SAN JOSE, Calif.--(BUSINESS WIRE)--Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the SmartChip ND™ Real-Time PCR System, an automated, research-use-only (RUO), high-throughput qPCR solution for infectious disease research. Takara Bio USA is now accepting orders of the SmartChip ND Real-Time PCR System..

加利福尼亚州圣何塞——（商业新闻短讯）——Takara Bio Inc.的全资子公司Takara Bio USA，Inc.今天宣布推出SmartChip ND™实时PCR系统，这是一种自动化的，仅供研究使用（RUO）的高通量qPCR解决方案，用于传染病研究。Takara Bio USA目前正在接受SmartChip ND实时PCR系统的订单。。

The SmartChip ND system meets laboratories’ needs for flexibility, scalability, efficiency, and affordability. The system’s customizable assay formats enable users to adapt panel compositions for various steps in the development process. One chip holds 5,184 reactions, accommodating 768 samples or up to 384 targets per sample in a single run.

SmartChip ND系统满足实验室对灵活性、可扩展性、效率和经济性的需求。该系统可定制的分析格式使用户能够针对开发过程中的各个步骤调整面板组成。一个芯片可容纳5184个反应，在一次运行中可容纳768个样品或每个样品多达384个靶标。

Automated dispensing, cycling, and analysis steps support a three-hour turnaround time from sample to data, with less than 30 minutes of direct hands-on time. Nanoliter-scale reactions reduce variability by eliminating the need for preamplification and reduce costs due to decreased reagent volumes..

自动分配、循环和分析步骤支持从样品到数据的三小时周转时间，直接动手时间不到30分钟。纳升规模的反应通过消除预放大的需要来减少可变性，并由于试剂体积减少而降低成本。。

As an alternative to culture-based pathogen detection techniques, SmartChip® technology enables research with its capacity for high-throughput detection of multiple infectious disease pathogens with high sensitivity and specificity. “We have found Takara Bio’s SmartChip technology to be a great choice for detecting viruses, bacteria, and fungi that cause urinary tract, sexually transmitted, and wound infections,” said Mehdi Dehghani, PhD, founder and CSO at BioExcel Diagnostics..

。BioExcel Diagnostics创始人兼CSO Mehdi Dehghani博士说：“我们发现Takara Bio的智能芯片技术是检测引起尿路、性传播和伤口感染的病毒、细菌和真菌的绝佳选择。”。。

“We have collaborated extensively with our key partners to create the next-generation SmartChip ND system, which boosts output while saving costs and time,” said Carol Lou, President & CEO of Takara Bio USA. “This innovative platform, designed for ease of use and streamlined functionality, provides unmatched accuracy, reproducibility, and flexibility for broad pathogen research.

Takara Bio USA总裁兼首席执行官卡罗尔·卢（Carol Lou）表示：“我们与关键合作伙伴广泛合作，创建了下一代智能芯片ND系统，该系统可以提高产量，同时节省成本和时间。这个创新平台旨在简化功能，便于使用，为广泛的病原体研究提供无与伦比的准确性，可重复性和灵活性。

We believe this technology will pave the way for discoveries and advancements in clinical and infectious disease research and many other fields.”.

我们相信这项技术将为临床和传染病研究以及许多其他领域的发现和进步铺平道路。”。

The SmartChip ND Real-Time PCR System will be on display at the Association for Molecular Pathology 2024 Annual Meeting & Expo (Booth #1207) from November 19–23, 2024 in Vancouver, Canada. Attendees can learn more by joining Takara Bio’s innovation spotlight talk titled “A high-throughput qPCR system for flexible and cost-effective large panel assay development” on November 23.

SmartChip ND实时PCR系统将于2024年11月19日至23日在加拿大温哥华举行的2024年分子病理学协会年会和博览会（展位#1207）上展出。与会者可以通过参加11月23日Takara Bio的创新聚光灯讲座了解更多信息，该讲座题为“高通量qPCR系统，用于灵活且具有成本效益的大型面板分析开发”。

Takara Bio experts will also present a poster on a “Comprehensive UTI assay panel utilizing exogenous DNA spike-in control for improved detection accuracy.” Researchers and other professionals wanting details on the SmartChip ND system can sign up to receive priority access to product and technical information..

Takara生物专家还将在“利用外源DNA加标控制提高检测准确性的综合UTI检测小组”上发布海报。希望了解SmartChip ND系统详细信息的研究人员和其他专业人员可以报名优先获取产品和技术信息。。

About Takara Bio

关于高良生物

Takara Bio USA, Inc. is a wholly owned subsidiary of Takara Bio Inc. that manufactures and distributes kits, reagents, and instruments for the life sciences, including NGS, PCR, gene delivery, genome editing, stem cell research, nucleic acid and protein purification, and automated sample preparation..

Takara Bio USA，Inc.是Takara Bio Inc.的全资子公司，生产和分销用于生命科学的试剂盒、试剂和仪器，包括NGS、PCR、基因传递、基因组编辑、干细胞研究、核酸和蛋白质纯化以及自动化样品制备。。

Takara Bio Inc., a world leader in biotechnology research and development, offers a host of life science research solutions, from enzymes and GMP-grade reagents to contracted cell and gene therapy manufacturing services and is the developer of the RetroNectin® reagent, a world standard in gene therapy protocols.

Takara Bio Inc.是生物技术研究和开发领域的世界领导者，提供了一系列生命科学研究解决方案，从酶和GMP级试剂到签约的细胞和基因治疗制造服务，并且是RetroNectin®试剂（基因治疗协议的世界标准）的开发人员。

Takara Bio is committed to preventing disease and improving the quality of life for all people through the use of biotechnology..

Takara Bio致力于通过使用生物技术来预防疾病和提高所有人的生活质量。。